Company news
Tianjin Lisheng Pharmaceutical Co., Ltd. Class A (SZSE:002393) news
Tianjin Lisheng Pharmaceutical Co., Ltd. Class A news releases on 6ix. Latest, Apr 24, 2026: Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY…
Press releases & updates
Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln
April 23, 2026
Tianjin Development Posts FY Results For Tianjin Lisheng Pharmaceutical
March 24, 2026
Tianjin Development Posts FY Total Revenue From Ops For Tianjin Lisheng Pharmaceutical RMB1.39 Bln
March 9, 2026
Tianjin Development Posts FY Net Profit Attributable Guidance For Tianjin Lisheng Pharmaceutical
January 23, 2026
Tianjin Development Says 9M Net Profit RMB374.3 Million For Tianjin Lisheng Pharmaceutical Co
October 23, 2025